Infective endocarditis in intravenous drug users

Area of Science:

• Infectious Diseases
• Cardiology
• Public Health

Background:

• Endocarditis epidemiology has evolved significantly since 1646.
• Modern endocarditis is increasingly associated with invasive procedures, medical devices, and intravenous drug use (IVDU).
• Risk factors include immunosuppression (diabetes, HIV), transplant medications, congenital heart disease, and prosthetic heart valves.

Purpose of the Study:

• To provide a comprehensive review of endocarditis in the context of intravenous drug use (IVDU).
• To examine the epidemiology, mechanisms, and treatment of IVDU-associated endocarditis.
• To discuss ethical dilemmas and future management strategies for this high-risk population.

Main Methods:

• Literature review focusing on endocarditis epidemiology, particularly related to IVDU.
• Analysis of risk factors, including immunosuppression and cardiac conditions.
• Exploration of current medical and surgical treatment modalities.
• Discussion of ethical considerations in managing high-risk patients.

Main Results:

• Endocarditis prevalence and associated factors have evolved due to technological advancements in detection and prophylaxis.
• IVDU is a major contemporary driver of endocarditis, affecting a specific high-risk demographic.
• Management requires addressing complex comorbidities and ethical challenges.

Conclusions:

• Endocarditis, especially in IVDU populations, presents unique epidemiological and clinical challenges.
• Comprehensive management strategies are needed, integrating medical, surgical, and ethical considerations.
• Further research into future directions for managing this lethal disease is crucial.